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Abstract
 
The CD45RA
 
hi
 
CD11c
 
int
 
 plasmacytoid predendritic cells (p-preDCs) of mouse lymphoid organs,
when stimulated in culture with CpG or influenza virus, produce large amounts of type I inter-
 
ferons and transform without division into CD8
 
 
 
CD205
 
 
 
 DCs. P-preDCs express CIRE, the
murine equivalent of DC-specific intercellular adhesion molecule 3 grabbing nonintegrin
(DC-SIGN). P-preDCs are divisible by CD4 expression into two subgroups differing in turn-
over rate and in response to 
 
Staphylococcus aureus
 
. The kinetics of bromodeoxyuridine labeling
and the results of transfer to normal recipient mice indicate that CD4
 
 
 
 p-preDCs are the imme-
diate precursors of CD4
 
 
 
 p-preDCs. Similar experiments indicate that p-preDCs are normally
long lived and are not the precursors of the short-lived steady-state conventional DCs. How-
ever, in line with the culture studies on transfer to influenza virus-stimulated mice the p-preDCs
transform into CD8
 
 
 
CD205
 
 
 
 DCs, distinct from conventional CD8
 
 
 
CD205
 
 
 
 DCs. Hence as
 
well as activating preexistant DCs, microbial infection induces a wave of production of a new DC
subtype. The functional implications of this shift in the DC network remain to be determined.
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Introduction
 
The ‘plasmacytoid T cell’ or ‘plasmacytoid monocyte’ of
human blood and lymphoid tissues puzzled pathologists for
decades. Eckert and Schmid (1) first suggested that these
 
cells were novel antigen presenting cells and indeed Grouard
 
(2) later identified these CD4
 
 
 
CD11c
 
 
 
 plasmacytoid (p)
 
cells as predendritic cells (preDCs)
 
*
 
 that, on culture with
IL-3, yielded functional DCs. Similar differentiation to DCs
was then shown to be induced by CD40 ligand (L) and by
viral and bacterial stimuli. These same stimuli were subse-
quently found to induce production of type I IFNs (3–5). It
has long been known that the p-preDCs migrate to in-
flamed lymph nodes and cluster around high endothelial
venules (for a review, see reference 6), and it is now known
that once there, they produce large amounts of type I IFN
(4, 5). Thus, as well as being preDCs, the plasmacytoid cells
proved to be the ‘natural IFN-producing cells’ which had
evaded virologists for many years (6). The response of these
p-preDCs to microbial stimuli appears to depend on a dis-
crete set of Toll-like receptors (TLRs; references 7–9) and
possibly other pattern recognition receptors. These findings,
of a dual antigen-presenting and IFN-producing role in re-
sponse to microbial invasion, have initiated investigations of
the role of p-preDCs in various infectious diseases (10–14).
The identification of the murine equivalent of the hu-
man p-preDCs paves the way to a detailed study of the
functions of this unusual cell type in models of microbial
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infections, tumors, and autoimmune disease. Several groups
simultaneously identified mouse CD11c
 
lo
 
B220
 
 
 
 cells of
plasmacytoid morphology as type I IFN-producing preDCs
(15–17). In a search for the precursors of CD8
 
 
 
 DCs we
recently reported the isolation of p-preDCs from mouse
blood and showed they are closely related to the human
blood p-preDCs (17a). We now report the characteristics
of these cells in mouse spleen, thymus, and lymph nodes,
and find that they express a unique pattern of surface mark-
ers, including the murine equivalent of DC-specific inter-
cellular adhesion molecule 3 grabbing nonintegrin (DC-
SIGN). We find they are separable by CD4 expression into
two functionally distinct subtypes that represent different
stages of differentiation. We demonstrate that in uninfected
mice these p-preDCs are long-lived and not the precursors
of the short-lived steady-state conventional CD8
 
 
 
 DCs.
However, upon bacterial or viral stimulation in vivo, as
well as in vitro, they then produce a separate wave of a dif-
ferent subtype of CD8
 
 
 
 DCs. This points to a significant
change in the nature of the DCs present in uninfected ver-
sus infected individuals.
 
Materials and Methods
 
Mice.
 
Mice were bred under specific pathogen free conditions
in the Walter and Eliza Hall Institute (WEHI) animal breeding fa-
cility. Male and female C57BL/6J WEHI mice (Ly 5.2) were used
at 6–9 wk of age. T cells used in allostimulatory mixed leukocyte
reactions (allo-MLR) were from CBA CaH WEHI mice. The re-
cipients used for cell transfer experiments were age and sex-
matched mice of the C57BL/6 Ly-5.1 Pep
 
3b
 
 strain.
 
Immunofluorescent Labeling of DCs.
 
Most of the mAb, the flu-
orescent conjugates, and the multicolor labeling procedures have
been specified previously (18). For sorting CD11c
 
 
 
CD45RA
 
 
 
conventional DCs and CD11c
 
int
 
CD45RA
 
hi
 
 p-preDCs from lym-
phoid organs, anti-CD11c (N418)-FITC conjugate, and anti-
CD45RA (clone 14.8)-PE conjugate (BD Biosciences) were
used. For sorting p-preDC sub-populations the following mAb
were used: anti-CD45RA (clone 14.8)-PE, anti-CD4 (GK1.5)-
FITC, and anti-CD8
 
 
 
 (YTS169.4)-Cy-5. For surface phenotype
analyses the following mAb conjugates were used: anti-
41BBLigand (TKS-1)-biotin, anti–BP-1 (6C3)-biotin, anti-
CD1d (1B1)-FITC, anti-CD4 (GK1.5)-Alexa 594 or -FITC,
anti-CD5 (53–7.3)-biotin, anti-CD8
 
 
 
 (YTS169.4)-Cy5, anti-CD8
 
 
 
(53–5.8)-biotin, anti-CD11b (M1/70)-FITC, anti-CD11c (N418)-
Cy5, -FITC, or -Alexa-594, anti-CD14 (RmC5–3)-FITC, anti-
CD16/CD32 (2.4G2)-FITC, anti-CD18 (M18/2.a.12.17)-biotin,
anti-CD19 (ID3)-FITC or -biotin, anti-CD24 (M1/69)-FITC,
anti-CD25 (PC61)-FITC, anti-CD36 (clone 63)-FITC, anti-
CD38 (NIM-R5)-biotin, anti-CD40 (FGK45.5)-FITC or biotin,
anti-CD43 (S7)-FITC, anti-CD45R (RA3–6B2)-FITC, anti-
CD45.2 (anti-Ly5.2, clone ALI-4A2)-biotin, anti-CD45RA
(14.8)-FITC, -PE, or -Cy-5, anti-CD45RB (MB23G2)-biotin,
anti-CD49d (PS/2)-FITC, anti-CD54 (YN1/1.7.4)-biotin, anti-
CD62L (MEL-14)-FITC, anti-CD80 (16–10A1)-FITC, anti-CD86
(GL1)-FITC, anti-CD115 (AFS98)-FITC, anti-CD127 (A7R34–
2.2)-biotin, anti-CD205 (DEC205, clone NLDC-145)-FITC,
anti-CIRE (murine DC-SIGN, clone 5H10)-biotin, anti-Ep-CAM
(G8.8)-biotin, anti-F4/80 (F4/80)-FITC, anti-Ly6C.2 (5075–
3.6)-FITC or -biotin, anti-Ly6G (RB68C5)-FITC or -biotin,
anti-MHC class II (N22 or M5/114)-FITC or -Alexa 594 (the
conjugation levels were deliberately less than maximal to ensure
the strong staining for class II MHC on DCs at saturation did not
cause color compensation problems in other channels), anti-NK
cell (DX-5)-biotin, anti-Sca-1 (E13161–7)-FITC, and anti–Sca-2
(E381–2.4)-biotin. Propidium iodide (PI) was included at 1 
 
 
 
g/ml
in the final wash after immunofluorescent staining to label dead
cells.
 
Flow Cytometric Sorting and Analyses.
 
For sorting conven-
tional DC and p-preDC populations a MoFlo instrument (Cyto-
mation Inc.) was used. Reanalysis was routinely performed and
populations were only used for further functional analyses when
the purity was 
 
 
 
95%. For cell transfer experiments care was
taken to use only p-preDCs that were 
 
 
 
98% pure. In most cases
an autofluorescent presort of DC preparations was performed on
the Mo-Flo instrument as described previously (18). This in-
volved sorting the cells before staining with any antibodies, but
after PI staining. Only those cells that were PI negative and
which did not fluoresce in the FITC or PE channels were col-
lected, yielding a preparation free of autofluorescent cells and of
dead cells. Most analyses were performed on a FACStar
 
Plus™
 
 in-
strument (Becton Dickinson) as described previously (18), using
up to four fluorescent channels for the immunofluorescent stain-
ing (FL1 for FITC, FL2 for PE, FL3 for Cy5, and FL4 for Alexa
594), with the FL5 channel set to exclude any residual PI-positive
dead cells or autofluorescent cells.
 
Purification of p-preDCs and DCs from Mouse Lymphoid Or-
gans.
 
DC preparations, containing conventional CD11c
 
hi
 
 DCs
and p-preDCs, were isolated from spleen, thymus, and subcuta-
neous and mesenteric lymph nodes using methods similar to
those described previously (18, 19). This involved mild collage-
nase digestion at room temperature, isolation of light density
cells, then immunomagnetic bead depletion of non-DC lineages.
To include B220
 
 
 
p-preDCs in the enriched DC preparation, the
critical difference was to replace anti-B220 (RA3–6B2) in the mAb
depletion cocktail with anti-CD19 (ID3). Increasing the density
of Nycodenz or leaving out anti-Gr-1 (RB6-8C5) from the de-
pletion cocktail did not increase the yield or change the pheno-
type of the p-preDCs recovered. For purification and segregation
of the populations of conventional and p-preDCs, the presorted
DC preparation, containing both cell types, was labeled with
anti-CD11c-FITC and anti-CD45RA-PE, and the two distinct
CD11c
 
int
 
CD45RA
 
hi
 
 (p-preDC) and CD11c
 
 
 
CD45RA
 
 
 
 (con-
ventional DC) populations were sorted using the MoFlo instrument.
Alternatively, to purify discrete sub-populations of p-preDCs, the
DC preparation was labeled with anti-CD45RA-PE, anti-CD4-
FITC, and anti-CD8-Cy-5 and the four CD45RA
 
hi
 
 subpopula-
tions were sorted: CD4
 
 
 
CD8
 
 
 
, CD4
 
 
 
CD8
 
 
 
, CD4
 
 
 
CD8
 
 
 
, and
CD4
 
 
 
CD8
 
 
 
.
 
Cytokines and Stimulants of preDCs.
 
Murine recombinant (r)GM-
CSF (used at 200 U/ml), murine (m)-rIL-3 (used at 100 U/ml),
m-rTNF-
 
 
 
 (used at 100 U/ml), and m-rIL-4 (used at 100 U/ml)
were gifts from Immunex Corporation, Seattle, WA. Recombi-
nant rat IFN-
 
 
 
 (used at 20 ng/ml and bioactive with mouse cells)
was purchased from PeproTech. Murine rIL-12 p70 was pur-
chased from R&D Systems. Oligonucleotides containing a fully
phosphorothioated CpG motif were synthesized by GeneWorks
Pty Ltd. according to a published sequence (CpG1668 [20]) and
used at 25–1,000 nM. All CpG sequences and their modifications
display differing effects on immune cells (for a review, see refer-
ence 21). The phosphorothiate CpG was initially chosen for its
extended half life in vitro and in vivo and then routinely used due
to the stimulatory effects it had on p-preDCs, which were less in- 
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tense but otherwise mimicked the response to flu virus. Pansorbin
(fixed and heat killed 
 
Staphylococcus aureus
 
 [SAC]) was purchased
from Calbiochem-Novabiochem. LPS and polyinosinic-polycyti-
dylic acid (poly I:C) were purchased from Sigma-Aldrich. Beta
propiolactone-inactivated (BPL) influenza A viruses (PR/8/34
and A/Guangdong/25/93) were provided by Michael Hocart,
Influenza Process Development, CSL Ltd., Melbourne, Australia.
Viable A/Guangdong/25/93 virus was from the Department of
Microbiology and Immunology, The University of Melbourne.
 
Differentiation and Activation of DCs in Culture.
 
Conventional DCs
and p-preDCs were incubated at 0.5 
 
 
 
 10
 
6
 
 cells/ml in U–bottom
wells of 96-well tissue culture plates, or in flat-bottom wells of
96- or 24-well tissue culture plates, in a humidified 10% CO
 
2
 
-in-air
incubator at 37
 
 
 
C for between 8 h and 6 wk. Modified, mouse
osmolarity, RPMI-1640 medium (22) was used, together with
the appropriate cytokines and stimulants as specified in the text.
 
Cell Cycle Analysis.
 
The cell cycle distribution of sorted
p-preDCs, freshly isolated or after overnight culture with 0.5 
 
 
 
M
CpG, was performed as described previously (23). Briefly, cells
were fixed with 70% ethanol, treated with 0.5 
 
 
 
g/ml DNase-free
RNase A (Boehringer) for 20 min at room temperature, and
stained with 69 
 
 
 
M PI in 0.1 M sodium citrate (pH 7.4) for 30
min at 4
 
 
 
C. Flow cytometric analysis was performed using a
FACScan™ II and cell cycle distribution was determined with
the Cellfit program (Becton Dickinson).
 
Phase Contrast Microscopy.
 
Cells were cultured for 8 h to 6 wk
in wells of 96- or 24-well flat-bottom culture plates. The cells
were visualized using the 
 
 
 
20 or 
 
 
 
40 objective of a Nikon Phase
Contrast inverted microscope and photographed with a con-
nected Nikon SLR camera using Eastman Kodak Co. 64T film.
 
MLR Cultures for T Cell Stimulation Capacity.
 
CD4
 
 
 
 T cells
were purified from pooled mesenteric, axillary, brachial, and in-
guinal lymph nodes of CBA/CaH mice as described previously
(24). Freshly isolated CD11c
 
int
 
CD45RA
 
hi
 
 preDC (1–4 
 
 
 
 10
 
3
 
) or
CD11c
 
hi
 
CD45RA
 
 
 
 conventional DC (1–4 
 
 
 
 10
 
3
 
) were added
to U-bottom wells containing 2 
 
 
 
 10
 
4
 
 T cells. Total culture vol-
ume was 100 
 
 
 
l in the modified RPMI 1640 medium described
above or in the same medium containing 200 U/ml GM-CSF
and 0.1 
 
 
 
M CpG. Replicate culture trays were incubated at
37
 
 
 
C in 10% CO
 
2
 
-in-air for 3–6 d. At days 3, 4, 5, 6, and 7 a culture
tray was pulsed with [
 
3
 
H]thymidine, 1 
 
 
 
Ci/well, for 6 h, then fro-
zen. The trays were thawed, the cells harvested onto glass fiber filters,
and the thymidine incorporated was counted by liquid scintillation.
All cultures at all times were at least in triplicate and background
controls, with T cells or preDCs only and with and without added
stimulants, were included at each time point.
 
Quantitation of Cytokine Production.
 
The analysis of IL-12
production in culture supernatants was performed by two-site
ELISA as described previously (25, 26). The detection of IL-6
also employed a two-site ELISA, using as capture antibody clone
MP5-20F3 and as detection antibody biotinylated clone MP5–
32C11. The IL-6 standard used was an IL-6 transfectant supernatant
(27) and the readout of the ELISA was exactly as that described
for IL-12. A bioassay for type I IFN was performed as described
previously (26). In addition, IFN-
 
 
 
 was assayed by a two-site
ELISA, using as a capture antibody anti-mouse IFN-
 
 
 
 (clone
RMMA-1; PBL Biomedical Laboratories) and as detection anti-
body a rabbit anti-mouse IFN-
 
 
 
 polyclonal (PBL Biomedical
Laboratories), followed by a F(ab
 
 
 
)
 
2
 
 fragment donkey-anti–rab-
bit-HRPO conjugate (Jackson Immunoresearch Laboratories).
The IFN-
 
 
 
 standard used was recombinant mouse IFN-
 
 
 
A (PBL
Biomedical Laboratories) and the readout of the ELISA was ex-
actly as that described for IL-12.
 
BrdU Treatment of Mice and Analysis of BrdU-labeled Cells.
 
Mice were given an initial intraperitoneal injection of BrdU (100
 
 
 
g in 100 
 
 
 
l PBS) at zero time and BrdU was administered con-
tinuously in drinking water for up to 14 d as described previously
(28). DCs were purified from treated mice as described above and
presorted to remove autofluorescent cells using the Mo-Flo in-
strument. The non-autofluorescent cells were stained with sur-
face markers and then fixed in 70% ethanol, followed by intracel-
lular staining for BrdU exactly as described previously (28), using
the anti-BrdU antibody B44 (BD Biosciences). The cells were
then analyzed using a FACStarPlus™ instrument.
Transfer of p-preDCs to Ly 5.1  Recipients. Sorted p-preDCs
from C57BL/6 Ly5.2  mice were washed in serum-free PBS and
injected either intravenously (1.5–2.5   106 cells/mouse, 200  l
volume) or into the footpad (0.4   106 cells/footpad, 15  l vol-
ume) or intrathymically (0.25   106 cells/lobe, 10  l volume)
into nonirradiated Ly5.1  recipients (three mice per group).
Treatment of Mice with Influenza Viruses. Groups of at least
three mice were injected intravenously with BPL-PR/8/34 or
BPL-Guandong/93, at doses of 40 to 4,000 hemagglutinating
units (HAU)/mouse, either once or on two consecutive days.
Mice that also received p-preDCs (as above), received virus 2 h
after transfer of p-preDCs.
Results
Isolation of p-preDC from Mouse Lymphoid Organs. We
recently isolated CD45RA  p-preDCs from mouse blood
(17a) and showed that on stimulation in culture with CpG
(oligonucleotides that mimic bacterial CpG motifs), these
cells rapidly produced large amounts of type I IFN, and also
became DCs and acquired surface CD8 . This raised the
question of whether the p-preDCs were precursors of the
CD8  DCs present in the lymphoid organs of normal labo-
ratory mice (18, 19). We therefore examined in detail the
p-preDCs present in mouse spleen, thymus, and lymph
nodes and designed experiments to determine if they were
the immediate precursors of the CD8  DCs of these organs.
To prepare the p-preDCs we first employed isolation
and enrichment procedures similar to those used to purify
mouse DCs, including selection of light-density cells and
immunomagnetic bead depletion of irrelevant cells. Im-
portantly, to remove B cells, we replaced anti-CD45R
(B220) mAb with anti-CD19, as we and others (15–17)
found that mouse p-preDCs express B220. Others have re-
ported that mouse p-preDCs stain with anti-Ly6G (GR-1),
perhaps due to cross-reactivity with other Ly6 molecules
(17). However, we obtained variable and always low stain-
ing of mouse p-preDCs with anti-GR-1. We found no
drop in p-preDC yield when anti–GR-1 was included in
the depletion cocktail nor any appearance of high anti–
GR-1 staining on p-preDCs when it was omitted. Ac-
cordingly, anti–GR-1 was usually included in the deple-
tion mAb cocktail.
To finally purify the p-preDCs, autofluorescent cells
were first eliminated in a presort and the remaining cells
were stained and sorted as CD45RAhiCD11cint cells. We
found CD45RA to stain more brightly than CD45R
(B220). We also found the p-preDCs from mouse lym-1310 Mouse Plasmacytoid Predendritic Cells
phoid tissues stained at intermediate levels for CD11c,
higher than the levels found in mouse blood p-preDCs, and
differing from the reported negative staining of CD11c on hu-
man p-preDCs (2). In all mouse lymphoid tissues this produced
a discrete population of p-preDCs, well segregated from the
CD45RA CD11chi conventional DCs (Fig. 1 A). The ratio of
CD45RAhiCD11cint p-preDCs to CD45RA CD11chi DCs
was 1:3 to 1:4 for spleen (Fig. 1 A), 1:3 for thymus and 1:1 for
lymph nodes (unpublished data).
Morphology of p-preDCs in Mouse Lymphoid Organs. Mi-
croscopy and light-scatter characteristics indicated the
mouse p-preDCs were round cells intermediate in size be-
tween lymphocytes and conventional DCs. Electron mi-
croscopy revealed cells with plasmacytoid morphology,
without dendritic processes, rather than conventional DC
morphology (data not shown). Endoplasmic reticulum was
not prominent in the majority of splenic p-preDCs, al-
though some cells showed the extensive endoplasmic retic-
ulum reported for human p-preDCs and that we have
found for mouse blood p-preDCs.
CD4 and CD8 Expression by Mouse p-preDCs. By using 3
or 4-color staining, the surface phenotype of the p-preDCs
was examined in detail. The first notable feature was that
the freshly isolated CD45RAhiCD11cint population, al-
though homogeneous by many markers, included cells
expressing CD4 and CD8  (but not CD8 ; Fig. 1). All
combinations of CD4 and CD8 expression were obtained,
allowing segregation into four populations (Fig. 1 A). This
was common to all mouse lymphoid tissue sources, which
all displayed similar proportions of the four populations, but
contrasted with mouse blood where we found all p-preDCs
were CD4 CD8  (17a).
Surface Markers on Mouse p-preDCs. The staining for a
range of other markers on mouse spleen p-preDCs is di-
Figure 1. Surface phenotype of mouse spleen p-preDCs compared with conventional DCs. Mouse spleen p-preDCs and conventional DCs were pu-
rified as described in Materials and Methods. The enriched preparation, after removal of autofluorescent cells, was stained for surface expression of
CD11c and CD45RA, together with staining for one or two other surface molecules. The p-preDCs (CD45RAhiCD11cint) and DCs
(CD45RA CD11chi) populations were gated as shown in A. The distribution of CD4 and CD8 on these (gated) populations is shown as a dot plot in A
and as histograms in B. The fluorescence distributions of a range of surface markers on the p-preDCs and conventional DC populations are shown in B;
the broken lines give the background fluorescence with only the relevant stain omitted. Not shown are the stains for the following surface molecules that
were negative (like CD40, as shown) on the preDC populations: 41BBLigand, CD14, CD18, CD19, CD80, CD86, CD115, NK cell marker (DX-5).
Surface staining for CIRE, the putative mouse DC-SIGN homologue is shown in C. The data of A are representative of more than 10 analyses, the data
of B and C are representative of 2–5 analyses.1311 O’Keeffe et al.
rectly compared with that of pooled conventional spleen
DCs in Fig. 1 B. This data confirms that we are studying
the same mouse p-preDC population as other groups who
have reported such a distinct pattern of markers, and also
introduces some new aspects of the p-preDC surface. The
p-preDCs expressed low surface levels of MHC II rather
than the moderate levels on quiescent conventional DCs;
however, p-preDCs showed intracellular MHC II by con-
focal microscopy (unpublished data). The p-preDCs also
lacked detectable expression of the costimulator molecules
CD40 (Fig. 1 B), CD80, and CD86 (data not shown), in
contrast to quiescent conventional DCs which expressed
low levels. This makes it unlikely that p-preDCs in an un-
stimulated form could activate naive T cells.
The lack of expression of various myeloid markers
(CD11b [Fig. 1 B], CD14, F4/80 [data not shown]) and
the expression of some markers found on mature or early
lymphoid cells (CD2, CD45R, Sca-1, Sca-2; Fig. 1 B)
hints at a possible lymphoid origin. Of note, although
these cells expressed CD45RA and CD45R (B220; Fig. 1
B), they did not express other B lineage markers such as
BP-1, CD21, CD19, or surface Ig (data not shown). Nor
did they express on the surface the NK-cell marker DX5,
nor the T cell markers TCR   , TCR   , nor CD3
chains (data not shown).
One difference to human p-preDCs is the much lower
expression of CD123 (IL-3 receptor) on mouse p-preDCs,
although it is positive (Fig. 1 B). CD127 (IL-7 receptor) is
low positive on the mouse p-preDCs.
A notable feature of the mouse p-preDCs is the high ex-
pression of Sca-1 (Ly 6A/E) and of Sca-2 (Ly-6E, TSA-1).
These are markers on early developmental stages of lym-
phoid lineage cells. Despite the high staining of these Ly-6
family members, including Ly 6C, our staining with GR-1
(Ly-6G) gave erratic and usually low to negative results,
much lower than the high staining of granulocytes, even
when GR-1 depletion was omitted from the isolation pro-
tocol. Similar results were obtained using a separate batch
of anti–GR-1 mAb provided by Drs. Asselin-Paturel and
G. Trinchieri (Schering-Plough, Dardilly, France).
One important difference from conventional DCs is that
as both CD11b and CD205 (DEC-205) are not expressed
by p-preDCs (Fig. 1 B), the expression of these markers did
not correlate with the CD8  and CD8  subdivisions as is
seen with conventional splenic DCs (18).
CIRE (DC-SIGN) on Mouse Spleen p-preDCs. A novel
DC-specific C-type lectin originally termed CIRE was just
identified on CD8  DCs and cloned in this laboratory by
Caminschi et al. (29). CIRE appears to be the closest mu-
rine equivalent of human DC-SIGN, a ligand of intercellu-
lar adhesion molecule (ICAM)-2 and ICAM-3 and also a
receptor for HIV-1 that facilitates transinfection of T cells
(29–31). The availability of a mAb against CIRE (unpub-
lished data) enables its expression on DC lineage cells to be
monitored. CIRE (DC-SIGN) is expressed by the majority
of spleen p-preDCs (Fig. 1 C). Cross-correlation studies
showed that only the fraction of splenic p-preDCs lacking
expression of both CD4 and CD8 did not express CIRE
(data not shown). The level of CIRE expression on p-preDC
was higher than on conventional quiescent DCs, where ex-
pression is limited to a subset of the CD8  DCs.
Culture of p-preDCs with Cytokines. To determine if
certain exogenous cytokines alone could induce p-preDCs
to secrete cytokines, or to differentiate into DCs, the
CD45RAhiCD11cint fraction from spleen was incubated
with various combinations of cytokines (Table I). These
cells died rapidly in culture in medium alone. GM-CSF
and IL-3, separately or together, enhanced survival, but did
not induce growth, differentiation to DCs, or cytokine
production, even on prolonged culture. However a modest
increase in surface MHC II expression was noted. IL-4 and
TNF- , factors used to produce and mature DCs from
monocytes, merely increased the rate of cell death. IL-6, a
factor found to induce DC production from bone marrow
cells (32), was without effect. No combination of the cy-
tokines used activated these p-preDCs to cytokine produc-
tion or produced cells with the shape or surface markers of
DCs, in contrast to results with human p-preDCs where
IL-3 alone induced some differentiation to DCs (3).
Induction of Cytokine Production by CpG. Stimulation of
the CD45RAhiCD11cint fraction with CpG alone acti-
vated the cells to production of type I IFN at high levels,
as well as to production of IL-6 and under appropriate
conditions to production of moderate levels of IL-12p70.
In addition the survival of the cells in culture was mark-
edly enhanced, including the reversal of the death-induc-
ing effects of IL-4 (Table I). These results were obtained
with p-preDCs from all murine sources tested, including
blood. This result indicated a close functional similarity to
human p-preDCs (3–5).
The conditions for optimal cytokine production induced
by CpG were then examined in detail (Table I). The pres-
ence of GM-CSF and/or IL-3 usually gave some improve-
ment in cell survival but did not alter type I IFN produc-
tion. As well as the bioassay, a specific ELISA confirmed
that IFN-  was present in the culture supernatants. IL-6,
assayed by a specific ELISA, was produced under all condi-
tions that induced IFN-  production. The level of production
of IL-12p70 was low with CpG alone, but was enhanced un-
der the conditions established as optimal for IL-12p70 pro-
duction by conventional CD8  DCs, namely CpG plus
GM-CSF, IFN- , and IL-4 (25). The level of IL-12p70
produced was still less than that obtained with conventional
splenic CD8  DCs and in contrast to CD8  DCs a very
high level of IL-12p40 (more than 0.1  g/ml) was still pro-
duced even in the presence of IL-4 (data not shown). Pro-
duction of IL-10 was not detected under any of the culture
conditions. These results were also obtained for each indi-
vidual fraction when the p-preDCs (CD45RAhiCD11cint)
were first segregated into four groups on the basis of CD4
and CD8 expression (as in Fig. 1 A) before culture.
Stimulation of DC Development by CpG. In contrast to the
results with cytokines alone, culture of the CD45RAhiCD11cint
fraction with CpG rapidly changed the appearance of the cells;
they clustered and within 1 d differentiated into cells with DC
morphology (Fig. 2 A). Similar results have been obtained1312 Mouse Plasmacytoid Predendritic Cells
with the equivalent fraction from blood. This demonstrates
that these cells are indeed preDCs. The morphological change
was even more dramatic on prolonged culture with CpG (Fig.
2 A). After 3 d some DC clusters produced long spindle-like
DCs, many of which were still viable with this extreme mor-
phology after 4 wk (Fig. 2 A), although the majority of DCs in
clusters had died by this stage. This long survival of some DCs
derived from preDCs is in marked contrast to the rapid death
in culture of conventional splenic CD8  DCs (28).
There was no increase in cell numbers after culture
with CpG (Table I) which, together with the speed of
the transition, suggested no cell expansion was involved.
Indeed PI staining of fixed samples of both freshly iso-
lated CD45RAhiCD11cint cells, and the cells after 12 h
culture with CpG, revealed only a sharp single 2n peak of
DNA, with no evidence of any cells in division cycle
(data not shown).
The Phenotype of DCs Generated in Culture from p-preDCs.
The surface phenotype of the DCs produced at various
times of culture was analyzed (Fig. 2 B). In contrast to even
prolonged culture with cytokines such as IL-3 and GM-
CSF, which resulted in only small increases in surface
MHC II, culture with CpG overnight resulted in a marked
increase in surface MHC II, together with increased levels
of CD11c and decreased levels of CD45RA (not shown);
these effects were amplified with extended culture times, to
produce a surface phenotype resembling by these markers
that of conventional splenic DCs, except for the persistence
of CD45RA (Fig. 2 B, and data not shown). This induc-
tion of DC morphology and phenotype was not caused by
the IL-6 production, as it was also obtained in the presence
of excess anti-IL-6 in the culture (data not shown). With
respect to expression of CD8, this increased on culture
with CpG; around 90% of the cells expressed moderate to
high levels of CD8  after overnight culture and this in-
creased on extended culture (Fig. 2 B). At the same time
the level of CD4 decreased, dropping to very low levels on
prolonged culture (data not shown), as is the case for CD4
expression by conventional DCs. Thus, all p-preDCs
served as precursors of CD4 /loCD8  DCs in culture.
However no CD205 was expressed, so the DCs differed in
this respect from conventional splenic CD8   DCs. Similar
results were obtained with p-preDCs from all murine
sources tested, including mouse blood (data not shown).
A hallmark of a mature DCs is the ability to stimulate
proliferation in allogeneic naive T cells in culture. Similar
Table I. Culture of Mouse Spleen Plasmacytoid Cells
Viable cell
recovery (% input)a
Cytokine
production day 1
Stimulus
and cytokines Day 1 Day 3 Type 1 IFN IL-6 IL-12p70
Transformation
to DC
Medium alone 30  10       
IL-4 17  10       
TNF  22  10       
IL-4   TNF  37  10       
IL-6 32  10   ND   
GM-CSF 51 25       
IL-3 45 28       
GM-CSF   IL-3 64 30       
CpG 69 50             
CpG   GM-CSF   IL-3 75 60             
CpG   GM-CSF   anti–IL-6 77 61     ND      
CpG   GM-CSF   IL-3   IFN-    IL-4 71 58              
LPS   GM-CSF   IL-3 54 30       
Poly I:C   GM-CSF   IL-3 61 25       
SAC   GM-CSF   IL-3 62 32    /   /  
Results are representative of 2–10 experiments. ND, not done. The absolute values of cytokines produced are shown in Fig. 3 and Fig. 6 C.
aViable cells recovered are means of duplicate samples. 1313 O’Keeffe et al.
to our results with mouse blood p-preDCs (17a), the
freshly isolated CD45RAhiCD11cint fraction from spleen
did not stimulate T cells in MLR culture (Fig. 2 C). How-
ever, when CpG (which produced detectable morphologi-
cal changes in p-preDCs within 2 h) was added directly to
the MLR cultures, the resultant activated p-preDCs did
stimulate T cell proliferation, albeit to a lesser extent than
that obtained with conventional splenic CD11c  DCs, ei-
ther freshly isolated or on culture with CpG (Fig. 2 C). A
similar enhancement of T cell stimulation capacity was seen
by preincubation of blood p-preDCs for 8 h with CpG,
before washing and testing the cells in the MLR cultures.
Differential Responses of p-preDCs to Different Microbial
Stimuli. A range of microbial and other stimuli were
tested to determine if they, like CpG, would activate mouse
p-preDCs (Table I and Fig. 3). In all cases stimuli found to
induce type I IFN production in culture also induced full
differentiation to DCs, and the pattern of response was the
same for spleen, thymus, and lymph node p-preDCs. Nei-
ther LPS nor poly I:C activated the CD45RAhiCD11cint
fraction to produce IFN- , nor did soluble or surface
bound anti-CD40 antibody FGK45.5 (Fig. 3, and data not
shown). However influenza virus Guangdong strain, either
live or inactivated, was a potent activator and induced 2–3
times more IFN-  than did CpG. The effectiveness of inac-
tivated virus and the lack of response to poly I:C indicated
that viral replication was not required for this activation.
The surface phenotype of the DC induced after virus acti-
vation was identical to that induced by CpG.
The Developmental Kinetics of Mouse p-preDCs and DCs.
The culture studies indicated that the CD45RAhiCD11cint
cells, whether CD4  or CD4 , could transform into
CD4 CD8  DCs, albeit with some differences in surface
phenotype from conventional spleen CD4 CD8  DCs.
This raised the question of whether the p-preDCs served as
the immediate precursors of the conventional CD4 CD8 
DCs in the lymphoid organs of normal laboratory mice. As
the CD45RAhiCD11cint p-preDCs and the CD4 CD8 
conventional DCs were present in similar numbers in
spleen, and as neither population was dividing, it was possi-
ble to check precursor-product relationship by following
the rate of acquisition of labeled cells during continuous
Figure 2. Phenotype of p-preDCs after culture. (A) Images of p-preDCs after 1 d, 3 d, or 4 wk culture in the presence of IL-3 and GM-CSF, with or
without CpG. Many cells died in the long term stimulated cultures, the results at 4 wk representing surviving cells. The original magnification was  20
(top panel) and  40 (all other panels). The images are representative of cultures from more than 20 preparations of sorted p-preDCs. (B) The MHC II
and CD8  surface phenotype of cells after 10 h culture of sorted spleen p-preDCs in IL-3 and GM-CSF alone, or together with LPS or CPG, is shown,
along with the phenotype of sorted p-preDCs after 35 h culture with IL-3 and GM-CSF alone, or together with LPS or CPG. The analyses are represen-
tative of more than 10 similar experiments. The recoveries of cells are indicated in Table I. (C) The ability of 2   103 p-preDCs to stimulate 2   104
CBA CD4  T cells in an MLR in the presence or absence of CpG. The stimulatory capacity of p-preDCs was compared with that of 2   103 conven-
tional DCs (purified at the same time), in the presence or absence of CpG. The average cpm of triplicate values is shown for each time point, the error
bars representing the range of triplicate values. The data shown are from a single experiment; similar results were obtained in a second experiment.1314 Mouse Plasmacytoid Predendritic Cells
administration of BrdU. As previously documented (28)
and now confirmed (Fig. 4), all the mature DC populations
of spleen had a fast turnover. The CD4 CD8  splenic DC
population had a very rapid turnover, 90% being positive
for BrdU uptake by 3 d. In marked contrast, the turnover
of the CD45RAhiCD11cint p-preDC population was slow,
only 10% being labeled by 3 d; it took 14 d of continuous
labeling before 90% of the cells were BrdU positive. Thus,
it was not numerically possible that the CD45RAhiCD11cint
cells were transforming directly into the CD4 CD8  con-
ventional splenic DCs in vivo. Nor could they be precur-
sors of the other splenic DC subsets. To check if both con-
ventional splenic DCs and splenic p-preDCs could be
independent products of the CD45RAhiCD11clo p-preDCs
of blood, the BrdU labeling kinetics of these latter cells was
examined. These rare blood p-preDCs (0.025% of mouse
peripheral blood mononuclear cells) did label faster than
spleen p-preDCs, with nearly 40% labeled after 3 d. How-
ever, although they could conceivably be the direct precursors
of the p-preDCs in spleen, they still did not turn over rapidly
enough to be the direct precursors of splenic CD8  DCs.
Overall, mouse p-preDCs appeared to be long-lived and
were developmentally distinct from the conventional DCs
normally present in mouse spleen. As the culture studies in-
dicated that a microbial stimulus was required to induce
DC production from p-preDCs, we checked if injection of
CpG would increase the turnover of p-preDCs. Injection
of CpG (0.3  mol per mouse) did increase the turnover of
p-preDCs, with around twice as many cells labeled at day 5
(Fig. 4). In addition there was a threefold increase in total
p-preDCs and of conventional DCs in the spleens (data not
shown). However, this enhanced turnover was still not suf-
ficient to generate the normal CD4 CD8  subset.
Influenza Virus as a Potent Stimulus of p-preDCs In Vivo.
It seemed impossible that in steady-state noninfected mice
the p-preDCs were generating the CD4 CD8  DC popu-
lation. This agreed with the culture data showing that mi-
crobial stimuli, rather than endogenous cytokines, were re-
quired to activate the p-preDCs. Although CpG was a
potent stimulus in culture, injection of CpG produced only
a modest activation of p-preDCs, as judged by size increase
and increase in CD11c and CD86 expression. However,
we found inactivated influenza virus, a more potent stimu-
lus in culture, produced marked activation and when in-
jected intravenously at low levels (4   102 HAU) appeared
to induce DC formation. At high levels (4   103 HAU),
Figure 3. Activated spleen p-preDC produce IFN- , IL-12, and IL-6.
(A) Bioassay for the production of type I IFN from p-preDCs cultured for
14 h with IL-3 and GM-CSF alone, or with additional cytokines and
stimulants. The “IL-12 inducing cytokines” were IL-3, GM-CSF, rat
IFN- , and IL-4. The values shown represent the means of duplicate
samples; similar results were obtained in three separate experiments. Cul-
turing of p-preDCs for up to 80 h yielded similar supernatant levels of
type I IFN. The production of type I IFN from p-preDCs stimulated
with BPL-Guangdong and live Guangdong virus was also shown by bio-
assay in a single experiment; the levels being higher than with CpG. (B)
ELISA for the production of IFN-  from p-preDCs cultured for 14 h in
the presence of IL-3 and GM-CSF together with the stimulants shown.
The results shown were similar to those obtained in three separate exper-
iments for LPS and BPL-Guangdong and in five separate experiments for
IL-3 and GM-CSF with or without CpG. The values shown are the
means of duplicate samples and the error bars represent the range. (C)
ELISA for the production of IL-12 p70 from spleen p-preDCs cultured
for 14 h with IL-3 and GM-CSF alone, or together with additional cy-
tokines and stimulants. IL-12 inducing cytokines were IL-3, GM-CSF,
rat IFN- , and IL-4. The values shown are the means of duplicate sam-
ples and the error bars represent the range; similar results were obtained in
three separate experiments. (D) ELISA for the production of IL-6 from
spleen p-preDCs cultured for 14 h with IL-3 and GM-CSF alone, or to-
gether with CpG. The values shown are the means of duplicate samples
and the error bars represent the range; similar results were obtained in
three separate experiments.
Figure 4. Spleen p-preDCs are long-lived cells compared with the
short-lived spleen DCs. BrdU was continuously administered to normal,
unstimulated, uninfected mice and at times from 2 h (the first time point)
to 14 d of labeling, spleen p-preDCs and conventional DCs were isolated,
stained for surface markers to delineate the subsets and stained for intra-
cellular BrdU to determine their BrdU-labeling kinetics. The labeling of
the three splenic conventional DC subsets is compared with that of the
total splenic p-preDCs and total blood p-preDCs; a single 5 d point com-
pares the labeling of spleen p-preDCs from mice injected once with CpG
(0.3  mol) at time zero. Results are the mean values from two separate
experiments, giving similar results, except for the CpG and 14 d points
which represent a single experiment.1315 O’Keeffe et al.
rapid activation was followed by a rapid loss of p-preDCs
and conventional DCs from spleen, to 25% control levels
(data not shown). The fate of these cells lost from the
spleen was not explored and the lower dose was used in
subsequent experiments.
Adoptive Transfer to Test for Virus-activated or Steady-State
PreDCs to DC Transformation. The complex shifts in the
DC population balance made it impossible to follow DC
generation from p-preDCs in response to influenza virus
stimulation within a single mouse. We therefore used an
adoptive transfer approach, injecting purified p-preDCs
from a Ly5.2 donor into a Ly5.1 nonirradiated recipient,
either unstimulated or virus-injected, and tracking the fate
of the transferred cells from 12 h to 4 d after transfer.
When 106 p-preDCs from spleen were transferred intra-
venously, it was possible to recover in the recipient spleen a
distinct population of donor (Ly5.2) type cells in the p-preDCs
enriched fraction at all time points that corresponded to at least
3% of the original transferred cells. When the p-preDCs were
transferred into nonstimulated normal recipients,  98% of the
recovered cells were unchanged even after 4 d, with main-
tenance of the surface phenotype CD45RAhiCD11cint and
no indication of maturation to a DC phenotype, such as
up-regulation of CD11c or MHC II (Fig. 5, and data not
shown). This agrees with the BrdU results indicating a very
slow turnover of the p-preDC population in normal mice.
Similar transfers were made by injecting thymic p-preDCs
directly into a recipient thymus; again the phenotype of the
donor-derived cells recovered from the recipient thymus
was unchanged and they had not become the typical thy-
mic CD8  DCs (data not shown).
In contrast, a single intravenous injection of inactivated
influenza virus (4   102 HAU) 2 h after intravenous trans-
fer of p-preDCs induced a change in surface phenotype of
the donor cells recovered in the recipient spleen 10 h later
(Fig. 5). Over 50% of the recovered donor-type cells
showed a reduction in CD45RA to intermediate levels and
an increase in CD11c expression, to a phenotype interme-
diate between p-preDCs and conventional splenic DCs. In
addition, these activated p-preDCs all expressed levels of
MHC II as high as on conventional DCs, and all expressed
CD8  but only low levels of CD4. These cells did not ex-
Figure 5. Mouse p-preDCs do not generate DCs on
transfer to an unstimulated recipient, but generate
CD8  DCs on transfer to an influenza virus-injected
recipient. Ly5.2 CD11cintCD45RA  p-preDCs (106)
were intravenously transferred to Ly5.1  recipient
mice that received either no stimulus or a single intra-
venous dose of 400 HAU of BPL-Guangdong virus 2 h
after cell transfer. 12 h after cell transfer the p-preDCs
and conventional DCs were purified from the recipient
mice and autofluorescent cells were removed by pre-
sorting. (A) The p-preDCs and conventional DCs
were stained with antibodies to Ly5.2, CD11c, and
CD45RA. The surface phenotypes of the gated Ly5.2 
cells from mice that received either no stimulus or in-
activated virus are compared. (B) After virus treatment
many of the Ly5.2  cells displayed a changed pheno-
type (Region 1(R1) cells). The surface phenotypes of
the donor-derived R1 cells and host conventional
CD8  DCs, both from mice that received inactivated
virus, were compared. The cells were stained with an-
tibodies against the following markers: Ly5.2,
CD45RA, and CD11c, together with CD8 or CD205
or MHC II or CD4. R1 cells were gated as in panel A.
Host conventional CD8  DCs were gated as
CD11c CD45RA  cells expressing either CD8 or
CD205, although for MHC II staining these cells were
gated as CD11c CD45RA  only since the level of
MHC II was the same on all of the conventional DCs
within this gate. The broken lines give the background
fluorescence with only the relevant stain omitted. Sim-
ilar results were obtained in five experiments for the
transfer of p-preDCs into hosts that received no stimu-
lus. Similar results were obtained in two experiments
for the transfer of p-preDCs into hosts that received
400 HAU of BPL-Guangdong virus and in a third ex-
periment where hosts received 400 HAU of BPL-PR/
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press CD205, in contrast to the CD8  DCs normally present
in the spleen. The in vivo progeny of the influenza virus stimu-
lated CD45RA CD11cint fraction therefore closely resembled
the DCs formed in culture in response to microbial stimuli.
Overall it appeared that only when there was a microbial
stimulus did the p-preDCs develop into DCs, and they
then produced a new wave of CD8  DCs, distinct from the
CD8  DCs normally present in an uninfected, unstimu-
lated laboratory mouse.
Two Developmental Stages of Mouse p-preDCs. To check
if the subsets of mouse spleen p-preDC segregated on the
basis of CD4 and CD8 expression represented sequential
steps in development, their relative rates of generation from
dividing precursors was examined. BrdU was continuously
administered to mice and the p-preDC fraction isolated as
in Fig. 4, but the individual subsets of p-preDC separated as
in Fig. 1 before analysis for BrdU incorporation. The re-
sults are shown in Fig. 6 A. While segregation by CD8 ex-
pression showed no differences in the rate of BrdU label-
ing, the CD4  and CD4  p-preDCs showed a marked
difference in kinetics. The CD4  cells (whether CD8  or
CD8 ) showed a more rapid labeling while the CD4  cells
(whether CD8  or CD8 ) showed a pronounced labeling
lag. This suggested a precursor-product relationship be-
tween CD4  and CD4  splenic p-preDCs with expression
of CD8 being irrelevant. As there was a lag in labeling of
the CD4  splenic p-preDCs and blood p-preDCs
(CD4 CD8 ) labeled even faster, this suggests a sequence:
blood p-preDCs →  spleen CD4  p-preDCs →  spleen
CD4  p-preDCs. Note that none of these subtypes of p-preDCs
showed a sufficiently fast turnover to generate and maintain
the conventional splenic CD8  DC population.
To test the hypothesis that the splenic CD4  p-preDCs
could be precursors of the splenic CD4  p-preDCs, we
transferred purified, sorted samples of each population from
Ly5.2  mice into normal, nonirradiated, and nonstimulated
Ly5.1 recipient mice. As indicated in Fig. 6 B, CD4  p-preDCs
did increase surface expression of CD4 so that 3 d after
transfer 20% expressed medium to high levels, whereas the
CD4  p-preDCs remained CD4  and also increased CD4
expression levels. This timing agrees with the BrdU label-
ing kinetic differences between the populations. Thus,
CD4  p-preDCs do become CD4  p-preDCs in normal,
unstimulated mice, but neither become a mature DC with-
out microbial stimulation.
Functional Differences Between Developmental Stages of
p-preDCs. We examined the four subsets of spleen p-preDCs
to determine if any of the subtypes or developmental stages
differed in response or function. Each of the microbial stimuli
of Fig. 3 had an identical activation effect, or lack of effect, on
the four subsets segregated on the basis of CD4 and CD8
expression. Indeed, CpG induced similar levels of IFN-  pro-
duction (Fig. 6 C) by all four p-preDC subsets and in all such
cultures the cells became CD11c MHCIIhiCD8  DCs (data
not shown). CpG induced down-regulation of CD4 in
both CD4  subsets and did not induce surface expression
of CD4 by the CD4  subsets (data not shown). This re-
sponse to CpG did not reveal any functional heterogeneity.
In contrast, the response to SAC revealed a functional het-
erogeneity according to CD4 expression (Fig. 6 C). Both
CD4  p-preDC subsets produced 10-fold more IFN- ,
with levels of cytokine similar to those induced by CpG. In
these SAC-activated cultures the CD4  p-preDCs but not
the CD4  p-preDCs produced cells of DC morphology,
Figure 6. Spleen p-preDCs subsets differ in function and developmental kinetics. (A) BrdU-label-
ing was performed as in Fig. 4 and p-preDCs were divided into subsets based on CD4 and CD8 ex-
pression. Results are the mean values from two separate experiments, giving similar results. (B) Sorted
CD4  or CD4  p-preDCs were transferred to Ly5.1  mice (without stimulus) as in Fig. 5. 3 d later
conventional and p-preDC subsets were harvested and cells were stained with antibodies against the
following markers: Ly5.2, CD4, CD45RA, and CD11c. Cells were gated based on high Ly5.2 ex-
pression and the CD4 expression level on these cells is shown. All Ly5.2  cells from both sets of mice
had maintained the original phenotype CD11cintCD45RAhi. (C) Spleen p-preDCs sorted on the basis
of CD4 and CD8 expression into four subsets, then cultured for 36 h in the presence of IL-3 and
GM-CSF alone or together with 500 nM CpG, 100  g/ml poly I:C, 10  g/ml LPS, or 10  g/ml
SAC. The cell supernatants were tested by ELISA for the production of IFN- . The values shown
are the means of duplicate samples and the error bars represent the range of these samples; similar re-
sults were obtained in three separate experiments.1317 O’Keeffe et al.
although they did not form such large DC clusters nor ex-
press as high levels of MHC II as those obtained by CpG
stimulation. Indeed the levels of MHC II were similar on
CD4  and CD4  p-preDCs, despite a lack of IFN-  pro-
duction by this latter subset. The production of IFN-  in
response to SAC was independent of the expression of
CD8. Thus, the biological response to one stimulus corre-
lated with the developmental sequence above, the earlier
CD4  p-preDCs showing greater response to SAC than
their later CD4  p-preDC progeny.
Discussion
In common with three other groups (15–17), and fol-
lowing our own studies on mouse blood (17a) we have
found the murine equivalent of the human plasmacytoid
cell, which we have termed p-preDCs. The key features of
this cell are that it is a major producer of type I IFN and si-
multaneously a precursor of DCs, both functions being ac-
tivated by microbial stimuli. Although there are some dif-
ferences from other reports, such as the extent of staining
with anti-GR1, most of the features align well with those
of other studies. We also present some novel features such
as the high levels of the early lymphoid and stem cell mark-
ers Sca-1 and Sca-2, members of the Ly6 family. Also of
particular interest is the expression of the putative human
DC-SIGN homologue CIRE, at levels higher than on
conventional DCs, on all p-preDCs except those lacking
both CD4 and CD8 expression.
Our study is the first to indicate that, despite many com-
mon features, the p-preDC population is heterogeneous,
not just in surface phenotype but in aspects of the biology
of these cells. Whether CD4  or CD4 , all of the p-preDCs
acquired CD8 expression after stimulus with CpG or virus.
As high levels of IL-6 and IFN-  were also produced un-
der these conditions, we tested whether these cytokines per
se influenced CD8 expression. High concentrations of anti-
bodies to IL-6 added to p-preDC cultures before addition
of CpG did not affect the acquisition of CD8 expression.
Likewise, mice which lacked expression of the type I IFN
receptor, and thus unable to respond to type I IFN, har-
bored p-preDCs expressing all combinations of CD4 and
CD8 and indeed CpG or viral stimulus of these cells re-
sulted in the acquisition of CD8 expression on the CD8 
populations (data not shown). Only the CD4  splenic p-preDC
subgroup shows a vigorous IFN-  response to SAC although
the response of CD4  and CD4  p-preDCs to CpG is equiv-
alent. The CD4  subgroup also shows a faster DNA-
precursor labeling and faster turnover than the CD4 
subgroup. It appears that these differences represent devel-
opmental stages of one lineage, rather than totally separate
cell types. The transfer studies indicate that CD4  p-preDCs
with time and without microbial stimulation acquire CD4,
whereas the CD4  p-preDCs remain CD4  unless sub-
jected to microbial stimuli. The DNA-precursor labeling
kinetics suggests a developmental sequence from blood
CD4  p-preDCs to spleen CD4  p-preDCs to spleen
CD4  p-preDCs. Tracking such development further back
to earlier dividing precursors and to hematopoietic precur-
sor cells is underway.
The difference in response to SAC during p-preDC de-
velopment is most likely due to differences in the expres-
sion of Toll-like or other pattern-recognition receptors.
Despite this difference, there must be much that remains
common in the distribution of pattern-recognition recep-
tors on the p-preDCs during their development, as they all
respond to influenza virus and CpG, but in contrast to con-
ventional DCs do not respond to LPS or poly I:C. The re-
sponse to virus is presumably due to recognition of an en-
velope protein rather than viral RNA, as inactivated virus is
effective and poly I:C is not.
Our main interest in these plasmacytoid cells was as pre-
cursors of DCs. As others had found, once effectively acti-
vated in vitro the p-preDCs not only secreted type I IFN,
but also rapidly transform into a cell with DC form and
function, with no evidence of cell expansion or entry of
the p-preDCs into the cell division cycle. The DCs so pro-
duced are all CD8  DCs, but they differ from the
CD4 CD8  DCs found in normal mouse spleen in lacking
expression of CD205, and in retaining some surface
CD45RA and CD4.
Our in vitro data raised the question as to whether these
plasmacytoid cells were the precursors of any of the DCs,
and particularly of the CD8  DCs, present in the lymphoid
organs of normal, noninfected laboratory mice. If they did
not act as precursors of normal DCs, was the production of
DCs in culture merely a laboratory artifact? Similar ques-
tions have been asked of the human plasmacytoid cells,
questions that could not readily be answered without the
BrdU labeling and adoptive transfer approaches we applied
to the murine p-preDCs.
Both the BrdU labeling studies on the intact mice and
the transfer studies using nonirradiated uninfected normal
recipient mice indicated that both splenic and thymic mu-
rine p-preDC are relatively long-lived cells which in a nor-
mal noninfected laboratory mouse maintain their plasmacytoid
state and do not transform into DCs. They could not be
the precursors of the rapidly turning-over conventional
CD8  DCs found in normal mice. In kinetic studies we would
not be able to detect a small proportion of p-preDCs produc-
ing the normal CD8  DCs via extensive cell division, but
we found no evidence of such division in either the p-preDC
or the conventional CD8  DC populations, and the trans-
fer studies negated this model. The immediate precursors of
the conventional mouse CD8  DCs are not p-preDCs.
However, a recent publication by Martinez del Hoyo et al.
(33) describes a CD11c MHC-II  cell population of mouse
blood that likely contains the immediate precursors of both
CD8  and CD8  DCs. Whether this newly identified pop-
ulation is homogeneous, meaning that identical precursor cells
give rise to CD8  and CD8  DCs, or is heterogeneous,
containing separate precursors for these two DC populations,
is not yet clear.
In response to stimulation by influenza virus the p-preDCs
did transform into CD4loCD8  DCs within recipient mice,1318 Mouse Plasmacytoid Predendritic Cells
indicating that they can generate DCs in vivo if provided
with an appropriate microbial stimulus. This is in complete
agreement with the culture studies. These microbial stimu-
lus induced DCs represent a new wave of CD8  DCs dif-
fering in origin from those present in the steady-state, and
indeed their surface phenotype differs from steady-state
CD8  DCs in several aspects, including CD205 expression.
Although it served to demonstrate the principal of micro-
bial induced p-preDCs to DC transformation in vivo, our
system involving the injection of low levels of inactivated
influenza virus intravenously is not an appropriate model of
infection by virus, as influenza infection would normally be
initiated in the lung. It is clear that the localization, activa-
tion, and life span of the p-preDCs and their DC progeny
will have to be considered in detail for different infectious
disease situations.
These findings add a new concept to the existing evi-
dence that ‘danger’ signals and microbial infections shift the
DC population from a quiescent, perhaps tolerogenic, state
to an activated state initiating immunity (34–36). They in-
dicate that, at least for the CD8  DCs, microbial infection
initiates a new wave of production of a new type of DCs
from these p-preDCs. This could indicate a shift in balance
from a population of tolerogenic DCs to a new set of im-
munogenic DCs, or a shift in the nature of the immune re-
sponse that can be generated. If the DCs generated from
the p-preDCs on stimulation in vivo survive as long as
those that develop in culture, they could have the function
of inducing and maintaining T cell memory. A careful
study of the functional differences between the steady-state
and the induced CD8  DCs forms should now provide
some answers to these crucial questions. The present study
sets the scene and demonstrates clearly that the rapidly
turning-over CD8  DCs of normal, uninfected mice are
not, as might have been thought, the progeny of the IFN-
producing plasmacytoid cells.
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